Teva settles with Oklahoma for $85 million in opioid case
One of the drugmakers named in Oklahoma's lawsuit over the opioid crisis has agreed to a settlement in which it will pay the state $85 million.
States bring price fixing suit against generic drug makers
Attorneys general from more than 40 states are alleging the nation’s largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions.
Drugmaker to pay $1.2 billion to settle ‘pay for delay’ lawsuit
The Federal Trade Commission announced today it has settled a lawsuit against drug company Cephalon, now owned by Teva Pharmaceutical Industries, for $1.2 billion – the largest settlement of its kind to date.
Additional Support Provided By:
